SHELLY SCHUTTE: Open Payments
NPI 1588696413 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 15 payments from 10 companies in 2025. Trend: 2023 $40 · 2024 $281 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 2 | $64 |
| SANOFI-AVENTIS U.S. LLC | 3 | $55 |
| Amgen Inc. | 2 | $34 |
| ABBVIE INC. | 2 | $32 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $31 |
| Dexcom, Inc. | 1 | $17 |
| KYOWA KIRIN, INC. | 1 | $17 |
| Abbott Laboratories | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: MINIMED 780G, TZIELD, TEPEZZA, ISTURISA, Dexcom G6 Transmitter, CRYSVITA, ETERNA, Kerendia.
Industry payments across NE — which companies pay providers there.
